Several studies reported that multiple components of the ATR pathway such as CHK1 [44], HUS1 [45], and Claspin [46], or other ATR substrates, profoundly affected CFS integrity when defective. This evidence concerns the gene HUS1 and myalgic encephalomeyelitis/chronic fatigue syndrome.